• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX30030X
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923); Material Deformation (2976); Physical Resistance/Sticking (4012)
Patient Problems Patient Problem/Medical Problem (2688); No Information (3190)
Event Date 06/18/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the procedure, an attempt was made to use one resolute onyx drug eluting stent to treat a moderately tortuous lesion located in the mid right coronary artery.There were no abnormalities reported in relation to anatomy.There was no damage noted to packaging.There were no issues noted when removing the device from the hoop.The device was inspected with no issues identified.The lesion was pre-dilated.The device did not pass through a previously-deployed stent.Resistance was encountered when advancing the device.It was reported that while passing through the guide towards the lesion the stent did not pass through.Some force was applied and while taking back, the device dislodged.Then dislodged stent was removed with surgery.Patient status post-procedure is alive with no injury.
 
Manufacturer Narrative
Additional information received reported that the lesion exhibited minimal stenosis and calcification.No difficulties were noted when removing the protective sheath.Negative prep was not performed.The inflation device remained on neutral pressure during delivery of the device.The stent was removed at the femoral level by making a small incision to remove it.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Evaluation summary: a kink was evident on the hypotube 12.1cm distal to the strain relief.The stent was not present on the balloon and did return for analysis.Crimp impressions were visible on the exposed balloon surface.The balloon folds remained intact.The dislodged stent returned stretched, bunched and deformed.The inner lumen patency could not be verified with a 0.015 inch mandrel most likely due to hardened blood.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway,ie
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway,ie
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7689074
MDR Text Key114007897
Report Number9612164-2018-01739
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/15/2020
Device Catalogue NumberRONYX30030X
Device Lot Number0008997000
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/27/2018
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/19/2018
Initial Date FDA Received07/16/2018
Supplement Dates Manufacturer Received07/20/2018
08/08/2018
09/21/2018
Supplement Dates FDA Received08/14/2018
10/03/2018
10/16/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-